IBM is the leading US company in terms of AI patents, but has not been able to effectively leverage this position for growth stimulation. This analysis examines the various avenues through which IBM deploys its patents, such as licensing to third parties, patent sales, and granting patents for public use. It also assesses the financial impact of patent sales and licensing, IBM’s advancements in AI across various sectors, and its market share and revenue growth resulting from these developments.